{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:21:18Z","timestamp":1787800878598,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021MH354"],"award-info":[{"award-number":["ZR2021MH354"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01812-9","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T02:23:35Z","timestamp":1747794215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic syndrome and bladder cancer risk: a comprehensive evidence synthesis combining bibliometric and meta-analysis approaches"],"prefix":"10.1186","volume":"25","author":[{"given":"Yi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"6865","key":"1812_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/414782a","volume":"414","author":"P Zimmet","year":"2001","unstructured":"Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782\u20137.","journal-title":"Nature"},{"issue":"9468","key":"1812_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415\u201328.","journal-title":"Lancet"},{"key":"1812_CR3","doi-asserted-by":"crossref","unstructured":"Tanja S, Tone B, Hanno U, Jonas M, Christel H, Gabriele N, Anders E, Dorthe J, G\u00f6ran H, Randi S. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol. 2015;44(4).","DOI":"10.1093\/ije\/dyv001"},{"issue":"3","key":"1812_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","volume":"61","author":"CD Nunzio","year":"2012","unstructured":"Nunzio CD, Aronson W, Freedland SJ, Giovannucci E, Parsons JK. The correlation between metabolic syndrome and prostatic diseases. Eur Urol. 2012;61(3):560\u201370.","journal-title":"Eur Urol"},{"issue":"1","key":"1812_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10549-014-3076-6","volume":"147","author":"F Berrino","year":"2014","unstructured":"Berrino F, Villarini A, Traina A. Metabolic syndrome and breast cancer prognosis. Breast Cancer Res Treat. 2014;147(1):159\u201365.","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"1812_CR6","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Karim C, Mshs M. Bladder cancera review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"issue":"3","key":"1812_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10147-020-01834-3","volume":"26","author":"HY Lee","year":"2021","unstructured":"Lee HY, Tang JH, Chen YH, Wu WJ, Juan YS, Li WM, Chan TC. The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database. Int J Clin Oncol. 2021;26(3):569\u201377.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"1812_CR8","doi-asserted-by":"publisher","first-page":"e0264634","DOI":"10.1371\/journal.pone.0264634","volume":"17","author":"T L\u00f3pez-Jim\u00e9nez","year":"2022","unstructured":"L\u00f3pez-Jim\u00e9nez T, Duarte-Salles T, Plana-Ripoll O, Recalde M, Xavier-Cos F, Puente D. Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study. PLoS ONE. 2022;17(3):e0264634.","journal-title":"PLoS ONE"},{"issue":"1","key":"1812_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1186\/s12885-015-1769-9","volume":"15","author":"M Montella","year":"2015","unstructured":"Montella M, Maso M, Crispo A, Grimaldi M, Bosetti C, Turati F, Giudice A, Libra M, Serraino D, Vecchia CL. Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study. BMC Cancer. 2015;15(1):720.","journal-title":"BMC Cancer"},{"key":"1812_CR10","doi-asserted-by":"crossref","unstructured":"Xu S, Zhang GM, Guan FJ, Dong DH, Luo L, Li B, Ma XC, Zhao J, Sun LJ. The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China. World Journal of Surgical Oncology,13,1(2015-08-07) 2015;13(1):1\u20137.","DOI":"10.1186\/s12957-015-0631-5"},{"key":"1812_CR11","doi-asserted-by":"crossref","unstructured":"Garg T, Young AJ, O\u2019Keeffe-Rosetti M, Mcmullen CK, Kirchner HL. Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults. Urol Oncol. 2020;38(9).","DOI":"10.1016\/j.urolonc.2020.04.010"},{"key":"1812_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.canep.2018.12.006","volume":"58","author":"M Kim","year":"2019","unstructured":"Kim M, Kim IH, Lim MK, Kim Y, Park B. Increased prevalence of metabolic syndrome in adult cancer survivors: Asian first report in community setting. Cancer Epidemiol. 2019;58:130\u20136.","journal-title":"Cancer Epidemiol"},{"key":"1812_CR13","unstructured":"Nan S. The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population."},{"issue":"3","key":"1812_CR14","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.7314\/APJCP.2014.15.3.1447","volume":"15","author":"E Ozbek","year":"2014","unstructured":"Ozbek E, Otunctemur A, Dursun M, Koklu I, Bozkurt M. Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder. Asian Pac J cancer Prevention: APJCP. 2014;15(3):1447\u201351.","journal-title":"Asian Pac J cancer Prevention: APJCP"},{"key":"1812_CR15","doi-asserted-by":"crossref","unstructured":"Tullika Garg MD, MPHab, Ajyms C, Orms D, Mm D, Matthew E, Nielsen MD, MSfg, Tem E, Hlk B. Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults - ScienceDirect. Urologic Oncology: Seminars Original Investigations. 2020;38(9).","DOI":"10.1016\/j.urolonc.2020.04.010"},{"key":"1812_CR16","unstructured":"Kei N. Shohei, Tobu, Shuhei, Kusano, Kohei, Takahara, Kazuma, Udo: the association between metabolic syndrome and High-Stage primary urothelial carcinoma of the bladder. Curr Urol. 2018."},{"issue":"1","key":"1812_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1741-7015-9-48","volume":"9","author":"K Gregory","year":"2011","unstructured":"Gregory K, Panagiota P, Eva K, George C. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9(1):48\u201348.","journal-title":"BMC Med"},{"key":"1812_CR18","doi-asserted-by":"publisher","first-page":"996440","DOI":"10.3389\/fonc.2022.996440","volume":"12","author":"S Fang","year":"2022","unstructured":"Fang S, Liu Y, Dai H, Gao T, Zeng L, Sun R, Zheng Z, Yuan J, Xia B, Pan Y. Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study. Front Oncol. 2022;12:996440.","journal-title":"Front Oncol"},{"key":"1812_CR19","doi-asserted-by":"crossref","unstructured":"Martinez Leal I, Pillai AB, Foreman JT, Siu KW, Heredia NI, Escalante CP, Manzullo EF, Christie AJ, Lacourt TE, Razouki ZA et al. A Qualitative Study of the Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome. Cancers (Basel). 2024;16(18).","DOI":"10.3390\/cancers16183147"},{"key":"1812_CR20","doi-asserted-by":"crossref","unstructured":"Veronica V, Giuseppe P, Laura S, Rossana M, Riccardo V, Vincenzo P, Antonino B. A novel autocrine loop involving IGF-II and the insulin receptor Isoform-A stimulates growth of thyroid Cancer. J Clin Endocrinol Metab. 2002;(1):245\u201354.","DOI":"10.1210\/jc.87.1.245"},{"key":"1812_CR21","doi-asserted-by":"crossref","unstructured":"Diabetes. and Cancer: a consensus report. Ca Cancer J Clin. 2010;60(4).","DOI":"10.3322\/caac.20078"},{"key":"1812_CR22","doi-asserted-by":"crossref","unstructured":"Belfiore A, Rapicavoli RV, Le Moli R, Lappano R, Morrione A, De Francesco EM, Vella V. IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? Biomedicines. 2023;11(1).","DOI":"10.3390\/biomedicines11010229"},{"issue":"25","key":"1812_CR23","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1038\/s41388-022-02353-3","volume":"41","author":"A Kerr","year":"2022","unstructured":"Kerr A, Baxter RC. Noncoding RNA actions through IGFs and IGF binding proteins in cancer. Oncogene. 2022;41(25):3385\u201393.","journal-title":"Oncogene"},{"issue":"1","key":"1812_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41232-022-00198-7","volume":"42","author":"R Hachiya","year":"2022","unstructured":"Hachiya R, Tanaka M, Itoh M, Suganami T. Molecular mechanism of crosstalk between immune and metabolic systems in metabolic syndrome. Inflamm Regen. 2022;42(1):13.","journal-title":"Inflamm Regen"},{"key":"1812_CR25","doi-asserted-by":"crossref","unstructured":"Akhter N, Wilson A, Arefanian H, Thomas R, Kochumon S, Al-Rashed F, Abu-Farha M, Al-Madhoun A, Al-Mulla F, Ahmad R et al. Endoplasmic reticulum stress promotes the expression of TNF-alpha in THP-1 cells by mechanisms involving ROS\/CHOP\/HIF-1alpha and MAPK\/NF-kappaB pathways. Int J Mol Sci. 2023;24(20).","DOI":"10.3390\/ijms242015186"},{"issue":"1","key":"1812_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s10020-024-01019-y","volume":"30","author":"MS Islam","year":"2024","unstructured":"Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M, Pan F. The interplay of factors in metabolic syndrome: Understanding its roots and complexity. Mol Med. 2024;30(1):279.","journal-title":"Mol Med"},{"key":"1812_CR27","doi-asserted-by":"publisher","first-page":"1368079","DOI":"10.3389\/fendo.2024.1368079","volume":"15","author":"D Dilixiati","year":"2024","unstructured":"Dilixiati D, Waili A, Tuerxunmaimaiti A, Tao L, Zebibula A, Rexiati M. Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024;15:1368079.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"1812_CR28","doi-asserted-by":"publisher","first-page":"e0311492","DOI":"10.1371\/journal.pone.0311492","volume":"19","author":"X Wang","year":"2024","unstructured":"Wang X, Jiang R, Shen J, Chen S, Wu S, Hu H, Cai H. Transitions in metabolic syndrome and metabolic obesity status over time and risk of urologic cancer: A prospective cohort study. PLoS ONE. 2024;19(10):e0311492.","journal-title":"PLoS ONE"},{"key":"1812_CR29","doi-asserted-by":"crossref","unstructured":"Haggstrom C. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer J Int Du Cancer. 2015;128.","DOI":"10.1002\/ijc.25521"},{"issue":"17","key":"1812_CR30","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1056\/NEJMp030029","volume":"348","author":"HO Adami","year":"2003","unstructured":"Adami HO, Trichopoulos D. Obesity and mortality from cancer. N Engl J Med. 2003;348(17):1623\u20134.","journal-title":"N Engl J Med"},{"key":"1812_CR31","doi-asserted-by":"crossref","unstructured":"Qin Q, Xu X, Wang X, Zheng XY. Obesity and risk of bladder cancer: A Meta-analysis of cohort studies. Asian Pac J cancer Prevention: APJCP. 2013;14.","DOI":"10.7314\/APJCP.2013.14.5.3117"},{"issue":"3","key":"1812_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00030.2014","volume":"95","author":"J Emily","year":"2015","unstructured":"Emily J, Gallagher D. Obesity and diabetes: the increased risk of Cancer and Cancer-Related mortality. Physiol Rev. 2015;95(3):727\u201348.","journal-title":"Physiol Rev"},{"issue":"10","key":"1812_CR33","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10552-008-9197-7","volume":"19","author":"L Magura","year":"2008","unstructured":"Magura L, Blanchard R, Hope B, Beal JR, Schwartz GG, Sahmoun AE. Hypercholesterolemia and prostate cancer: a hospital-based case\u2013control study. Cancer Causes Control. 2008;19(10):1259\u201366.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"1812_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/qjmed\/hcr243","volume":"105","author":"PJ Rosch","year":"2012","unstructured":"Rosch PJ. The statin-low cholesterol-cancer conundrum. Qjm Monthly J Association Physicians. 2012;105(4):383\u20138.","journal-title":"Qjm Monthly J Association Physicians"},{"issue":"4","key":"1812_CR35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","volume":"59","author":"T Stocks","year":"2012","unstructured":"Stocks T, Hemelrijck MV, Manjer J, Bjorge T, Ulmer H, Hallmans G, Lindkvist B, Selmer R, Nagel G, Tretli S. Blood pressure and risk of Cancer incidence and mortality in the metabolic syndrome and Cancer project. Hypertension. 2012;59(4):802\u201310.","journal-title":"Hypertension"},{"key":"1812_CR36","unstructured":"Hypertension. Diuretics and antihypertensives in relation to bladder cancer. Carcinogenesis. 2010."},{"issue":"16","key":"1812_CR37","doi-asserted-by":"publisher","first-page":"e7400","DOI":"10.1002\/cam4.7400","volume":"13","author":"T Lopez-Jimenez","year":"2024","unstructured":"Lopez-Jimenez T, Plana-Ripoll O, Duarte-Salles T, Recalde M, Bennett M, Xavier-Cos F, Puente D. Exploring the association between metabolic syndrome, its components and subsequent cancer incidence: A cohort study in Catalonia. Cancer Med. 2024;13(16):e7400.","journal-title":"Cancer Med"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01812-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:03:55Z","timestamp":1747839835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01812-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01812-9","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}